Caring for Carcinoid Foundation-AACR Grants for Carcinoid Tumor and Pancreatic Neuroendocrine Tumor Study: These two-calendar year grants of $250,000 are open to independent junior and senior investigators to develop and study new suggestions and innovative approaches which have direct software and relevance to carcinoid tumors or pancreatic neuroendocrine tumors. Related StoriesPatrolling monocytes may play anti-cancer role in the lungNew studies suggest ways to improve cancer treatment by inhibiting oncogenes, boosting tumor-suppressor activityResearchers recognize tumor suppressor genes that get subset of melanomasThrough this joint effort, AACR and CFCF desire to increase the understanding of neuroendocrine tumor biology, elucidate the mechanisms of available therapies currently, and identify new treatment targets for carcinoid and pancreatic neuroendocrine tumors.In the usa, nearly one in 10 people, or about 2.7 million Us citizens, develop AFib in their lifetimes. Atrial fibrillation can be a quivering or irregular heartbeat that can lead to blood clots, stroke, heart failing and other heart-related problems. Physicians make an effort to achieve a global normalized ratio of 2-3, which is at the therapeutic range, or the basic safety range. Typically, dosages higher than the therapeutic range can raise the threat of bleeding. If the dose is lower compared to the therapeutic range, it could increase risk of blood clots forming. Three years ago researchers at the Intermountain INFIRMARY Heart Institute discovered that patients with atrial fibrillation were at higher risk for developing dementia, however the reason behind that association – the link between anticoagulation dementia and medication – was unknown.